DE60101309D1 - Diacerein zur behandlung von psoriasis - Google Patents

Diacerein zur behandlung von psoriasis

Info

Publication number
DE60101309D1
DE60101309D1 DE60101309T DE60101309T DE60101309D1 DE 60101309 D1 DE60101309 D1 DE 60101309D1 DE 60101309 T DE60101309 T DE 60101309T DE 60101309 T DE60101309 T DE 60101309T DE 60101309 D1 DE60101309 D1 DE 60101309D1
Authority
DE
Germany
Prior art keywords
diacerein
treating psoriasis
psoriasis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60101309T
Other languages
English (en)
Other versions
DE60101309T2 (de
Inventor
Napoli Guido Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Medidom SA
Original Assignee
Laboratoire Medidom SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom SA filed Critical Laboratoire Medidom SA
Publication of DE60101309D1 publication Critical patent/DE60101309D1/de
Application granted granted Critical
Publication of DE60101309T2 publication Critical patent/DE60101309T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60101309T 2000-01-12 2001-01-08 Diacerein zur behandlung von psoriasis Expired - Lifetime DE60101309T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
CH53002000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (2)

Publication Number Publication Date
DE60101309D1 true DE60101309D1 (de) 2004-01-08
DE60101309T2 DE60101309T2 (de) 2004-09-16

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60101309T Expired - Lifetime DE60101309T2 (de) 2000-01-12 2001-01-08 Diacerein zur behandlung von psoriasis

Country Status (22)

Country Link
US (2) US6844365B2 (de)
EP (1) EP1248608B1 (de)
JP (1) JP4912554B2 (de)
CN (1) CN1187045C (de)
AR (1) AR026801A1 (de)
AT (1) ATE254913T1 (de)
AU (1) AU776324B2 (de)
BR (2) BR0107493A (de)
CA (1) CA2396111C (de)
CZ (1) CZ301129B6 (de)
DE (1) DE60101309T2 (de)
DK (1) DK1248608T3 (de)
ES (1) ES2210120T3 (de)
IL (2) IL150390A0 (de)
MX (1) MXPA02006610A (de)
PL (1) PL212010B1 (de)
PT (1) PT1248608E (de)
RU (1) RU2266740C2 (de)
SK (1) SK286589B6 (de)
TR (1) TR200400228T4 (de)
WO (1) WO2001051044A2 (de)
ZA (1) ZA200205148B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
JP5757495B2 (ja) 2005-05-16 2015-07-29 アッヴィ バイオテクノロジー リミテッド びらん性多発性関節炎の治療のためのｔｎｆ阻害剤の使用
EP2007426A4 (de) * 2006-04-10 2010-06-16 Abbott Biotech Ltd Anwendungen und zusammensetzungen zur behandlung von psoriasis-arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (de) 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracen-Sulfonat-Derivate
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
CN102858155B (zh) * 2010-04-08 2015-02-04 安成生物科技股份有限公司 使用双醋瑞因作为糖尿病的辅助治疗的方法
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
TWI794200B (zh) * 2017-01-19 2023-03-01 安成生物科技股份有限公司 預防或治療免疫發炎性皮膚疾病的方法及醫藥組合物
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
UA126941C2 (uk) * 2018-03-29 2023-02-22 С.І.С. Шулов Інновейтів Сайєнс Лтд. Фармацевтичні композиції для інгібування запальних цитокінів
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
PT1248608E (pt) 2004-04-30
ZA200205148B (en) 2003-06-26
CN1187045C (zh) 2005-02-02
US20020143057A1 (en) 2002-10-03
TR200400228T4 (tr) 2004-02-23
EP1248608B1 (de) 2003-11-26
JP2003519653A (ja) 2003-06-24
BR0107493A (pt) 2002-10-08
DK1248608T3 (da) 2004-04-05
CN1395484A (zh) 2003-02-05
AU2213201A (en) 2001-07-24
EP1248608A2 (de) 2002-10-16
CA2396111C (en) 2008-12-02
PL212010B1 (pl) 2012-07-31
US6844365B2 (en) 2005-01-18
MXPA02006610A (es) 2004-09-10
BRPI0107493B1 (pt) 2019-04-16
CZ301129B6 (cs) 2009-11-11
CZ20022382A3 (cs) 2002-11-13
IL150390A (en) 2007-07-24
ATE254913T1 (de) 2003-12-15
US20050004045A1 (en) 2005-01-06
SK9912002A3 (en) 2003-02-04
WO2001051044A3 (en) 2002-03-28
DE60101309T2 (de) 2004-09-16
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
AR026801A1 (es) 2003-02-26
ES2210120T3 (es) 2004-07-01
JP4912554B2 (ja) 2012-04-11
IL150390A0 (en) 2002-12-01
BRPI0107493B8 (pt) 2021-05-25
PL356784A1 (en) 2004-07-12
AU776324B2 (en) 2004-09-02
WO2001051044A2 (en) 2001-07-19
CA2396111A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
DE60117977D1 (de) Vorrichtungen zur behandlung von harninkontinenz
DE60101309D1 (de) Diacerein zur behandlung von psoriasis
DE60100851D1 (de) Piperidin verbindung zur behandlung von psoriasis
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
DE60120520D1 (de) Verfahren zur behandlung von abwasser
DE60041430D1 (de) Zusammensetzung zur Entfernung von Photoresist
DE60128501D1 (de) Zusammensetzung zur Entschichtung von Photoresist
DE60102016D1 (de) Verfahren zur behandlung von beweggungsstörungen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
ATE265860T1 (de) Impstoff zur behandlung von atherosclerosis
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE413375T1 (de) Retinoide zur behandlung von emphysem
DE60014928D1 (de) Retinoide zur behandlung von emphysem
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
ATE301266T1 (de) Vorrichtung zur behandlung von abfällen
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
DE69835419D1 (de) Verfahren zur Behandlung von organischem Abwasser
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE60115647D1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition